Shares of Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) were up 33.1% on Friday . The stock traded as high as $2.84 and last traded at $2.33. Approximately 17,077,000 shares were traded during mid-day trading, an increase of 2,754% from the average daily volume of 598,422 shares. The stock had previously closed at $1.75.

Separately, ValuEngine raised shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 11th.

ILLEGAL ACTIVITY NOTICE: “Ampio Pharmaceuticals (AMPE) Trading Up 33.1%” was reported by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with's FREE daily email newsletter.